PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
19-Aug-2024 Original-Research: Formycon AG (von First Berlin Equity Research GmbH) Formycon AG
16-Aug-2024 SYNBIOTIC Annual General Meeting on 20.09.2024: Increasing sales drive growth SYNBIOTIC SE
16-Aug-2024 New gastric & gastro-oesophageal junction cancer treatment VYLOY™ ▼ (zolbetuximab): the first claudin 18.2 biomarker targeted therapy licensed in Great Britain Astellas Pharma Ltd
16-Aug-2024 A-Level students urged to consider pharmaceutical careers Association of the British Pharmaceutical Industry (ABPI)
16-Aug-2024 New gastric & gastro-oesophageal junction cancer treatment VYLOY™ ▼ (zolbetuximab): the first claudin 18.2 biomarker targeted therapy licensed in Great Britain Astellas Pharma Ltd
16-Aug-2024 Original-Research: APONTIS PHARMA AG (von First Berlin Equity Research GmbH) APONTIS PHARMA AG
15-Aug-2024 CureVac Announces Financial Results for the Second Quarter and First Half of 2024 and Provides Business Update CureVac
15-Aug-2024 CureVac Advances Cancer Vaccine Candidate CVGBM to Part B of Phase 1 Study in Patients with Resected Glioblastoma CureVac
15-Aug-2024 CureVac Names Oncologist and Drug Development Expert Dr. Mehdi Shahidi to Supervisory Board CureVac
15-Aug-2024 AsiaMedic continues growth streak with 23% increase in revenue for First Half ended 30 June 2024 AsiaMedic Limited
14-Aug-2024 Half-year financial statements close with balanced EBITDA, Trauma with positive EBITDA aap Implantate AG
14-Aug-2024 NHS requires compliance with BSI Kitemark™ to promote responsible antibiotic manufacturing BSI
14-Aug-2024 Marinomed Biotech AG: Court opens restructuring proceedings without self-administration Marinomed Biotech AG
14-Aug-2024 Medios AG: Annual General Meeting resolves to expand the Supervisory Board to five members Medios AG
14-Aug-2024 Marinomed Biotech AG aims for financial reorganization by restructuring proceedings without self-administration Marinomed Biotech AG
14-Aug-2024 Sustained organic growth in high-margin existing branded pharmaceutical business Dermapharm Holding SE
14-Aug-2024 DOUGLAS Group continues strong financial and business performance in third quarter 2023/24 Douglas AG
14-Aug-2024 Evotec SE reports H1 2024 results: Challenging year; priority reset for sustainable profitable growth gaining momentum, building on core strengths Evotec SE
14-Aug-2024 Straumann Group reports strong growth in the second quarter and updates outlook due to selling DrSmile Straumann Holding AG
13-Aug-2024 Marinomed Biotech AG applies for court restructuring proceedings without self-administration Marinomed Biotech AG